Cipta Sarana Medika Tbk. vs Bank China Construction Bank Indonesia Tbk. — how do they compare? Cipta Sarana Medika Tbk. trades at Rp63 (market cap 158.12B, 8.21M 24h volume), while Bank China Construction Bank Indonesia Tbk. trades at Rp68 (market cap 2.52T, 1.21M 24h volume). The key difference: Bank China Construction Bank Indonesia Tbk. is far larger — about 15.9× Cipta Sarana Medika Tbk.'s market cap, and Cipta Sarana Medika Tbk. is more actively traded (8.21M versus 1.21M). Which is the better fit depends on your goals.
| DKHH | MCOR | |
|---|---|---|
Market Cap | 158.12B | 2.52T |
Volume | 8.21M | 1.21M |
Lot | 82.15K | 12.07K |
Turnover | 515.2M | 81.26M |
Average Price | 62.72 | 67.32 |
Value | 515.2M | 81.26M |
Indicative Equilibrium Price | 63 | 67 |
Indicative Equilibrium Volume | 1.33K | 1.8K |
Trailing returns across standard periods
Latest headlines on both assets
PT Cipta Sarana Medika Tbk (the Company) was established based on Deed No. 90 dated September 17, 2014 by Dede Fujianti, SH., M.Kn., Notary in Sukabumi. The Company ultimate parent entity is PT Siliwangi Djajakusumah Bersatu. The Company started its commercial operations in 2014.
Read more on DKHH →PT Bank Multicor (Bank) was established under its original name of PT Multinational Finance Corporation base on notarial deed No.4 of Mr Bagijo, S.H, dated on Apr 2, 1974. The Company’s articles of association has been amended several times, most recently by notarial deed No. 143 of Eliwati Tjitra, S.H., dated Mar 21, 2007, concerning among others, the change in the Company’s name, Anggaran Dasar and public offering. The Bank's name was changed to PT Bank Windu Kentjana International Tbk.
Read more on MCOR →